Company Search:
Advanced Search
Sponsored Links
Mesoblast Ltd - ADR Company Snapshot
Mesoblast Ltd - ADR operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Mesoblast Ltd - ADR with three other companies in this sector in the United States: Aytu Bioscience Inc (2017 sales of $3.22 million ), Nascent Biotech Inc ($3.00 million ), and Kalvista Pharmaceuticals Inc ($1.50 million ).

Sales Analysis. Sales fell dramatically in 2017: During the year ended June of 2017, sales at Mesoblast Ltd - ADR were $2.41 million. This is a sharp decrease of 94.3% versus 2016, when the company's sales were $42.55 million.
  Stock Performance Chart for Mesoblast Ltd - ADR
  Stock Data: Recent Stock Performance:
  Current Price (12/8/2017): 5.30
(Figures in U.S. Dollars)
1 Week 2.5%   13 Weeks 1.1%  
4 Weeks -9.9%   52 Weeks 10.9%  
Mesoblast Ltd - ADR Key Data:
  Ticker: MESO Country: United States
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 2,411,996
(Year Ending Jan 2018).
Employees: 75
  Currency: U.S. Dollars Market Cap: 494,922,026
  Fiscal Yr Ends: June Shares Outstanding: 93,381,514
  Share Type: Ordinary Closely Held Shares: 28,697,364
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.